% | $
Quotes you view appear here for quick access.

Novadaq Technologies Inc. Message Board

  • cynical_trader cynical_trader Apr 9, 2012 4:04 PM Flag

    $37M net... over-allotment exercised

    TORONTO, ONTARIO --(Marketwire - April 9, 2012 ) - Novadaq(R) Technologies Inc. ("Novadaq" or the "Company") (TSX:NDQ)(NASDAQ:NVDQ), a developer of real-time medical imaging systems for use in the operating room, today announced the closing of its previously announced public offering of 6,100,000 common shares at a public offering price US$5.75 per share. Prior to the closing, the underwriters exercised in full the option to purchase an additional 915,000 common shares at a price of US$5.75 per share solely to cover over-allotments.
    Gross proceeds from the offering were approximately US$40.3 million . After the underwriting commissions and other offering expenses, Novadaq received net proceeds of approximately US$36.9 million . Piper Jaffray & Co. and Stifel Nicolaus Weisel served as joint book-running managers for the offering, and JMP Securities LLC and Rodman & Renshaw, LLC served as co-managers for the offering. The common shares described above were sold by Novadaq in the United States pursuant to the Company's effective shelf registration statement filed with the U.S. Securities and Exchange Commission and in Canada pursuant to a final short form base shelf prospectus and prospectus supplement filed with the securities regulatory authorities in each of the provinces of Canada , except Quebec .
    Novadaq intends to use the net proceeds from this offering to fund the investments required to commercialize PINPOINT, the minimally invasive version of the Company's SPY technology, and for general corporate purposes including funding potential future acquisitions, capital expenditures, the procurement of raw material supply and for future research and development of new product hardware, and new imaging molecules such as those required for nerve imaging.

11.71-0.14(-1.18%)Sep 27 4:00 PMEDT